News & Updates

Show Multimedia Only
Post-ICH antiplatelet therapy not linked to recurrent ICH

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021 byRoshini Claire Anthony

Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021